Tutorials › Multi-Arm Multi-Stage (MAMS) Designs › Prior Distributions for Arm-Specific Effects

Bayesian Multi-Arm Approaches · Tutorial 390 of 499

Prior Distributions for Arm-Specific Effects

Learn to calibrate arm-specific normal priors, calculate prior probabilities for treatment effects, and interpret what is—and is not—assumed when all arms use the same prior.

Advanced 10 min read

What You'll Learn

  • Define arm-specific effects on a stated scale and in a stated beneficial direction.
  • Interpret the mean and variance of a normal prior in the effect’s units.
  • Convert prior beliefs about meaningful effects into normal-prior probabilities.
  • Calculate joint prior probabilities under independence without rounding too early.
  • Distinguish identical independent priors from assuming equal effects or a shared parameter.
  • Diagnose implausible prior scales and identify when arm-specific priors may be warranted.

Why Specify Priors Arm by Arm?

In a multi-arm trial, each treatment arm can have its own effect relative to a defined reference. Before observing outcomes, a Bayesian analysis represents uncertainty about those effects with prior distributions. These distributions encode assumptions about plausible effect sizes and uncertainty; they are not estimates from the trial data. A clear prior specification therefore begins by defining the effect, its scale, and which direction represents benefit.

This tutorial considers independent normal priors for arm-specific effects. “Independent” describes the joint prior assumptions about the effects, while “normal” describes each effect’s marginal distribution. The assumptions are useful to state explicitly: using the same normal distribution for several arms does not assert that their true effects are equal.

Definition: Let \(\theta_j\) denote the treatment effect for arm \(j\), measured as a contrast against a prespecified reference on a stated additive scale. An independent normal prior specification is $$ \theta_j \sim N(m_j,v_j), \qquad j=1,\ldots,K, $$ with the \(\theta_j\) mutually independent before observing the data. Here \(m_j\) is the prior mean, \(v_j>0\) is the prior variance, and the prior standard deviation is \(\sqrt{v_j}\). The second argument of \(N(\cdot,\cdot)\) is the variance.

The meaning of \(\theta_j\) depends on the chosen outcome and contrast. For example, if the outcome is a score and positive values represent improvement, \(\theta_j=2\) means an average improvement of two score points relative to the reference. The prior mean \(m_j\) is the center of prior belief about that effect. The variance \(v_j\) measures prior uncertainty in squared effect units: if effects are measured in score points, the variance is in score-points squared. A larger variance spreads more prior probability over values farther from the mean.

Normal priors are defined over the whole real line. They may be reasonable for an additive effect when values on both sides of zero are plausible and the prior places negligible mass on implausible extremes. If the effect scale or scientific constraints make this inappropriate, a normal prior may be a poor choice. The specification also assumes that all arms’ effects are defined comparably enough for their prior locations and scales to be interpreted.

Calibrating a Normal Prior

One practical way to assess a proposed prior is to translate it into probabilities for effects that have a direct scientific interpretation. Let \(\Phi(z)\) denote the cumulative distribution function of a standard normal random variable. For \(\theta_j\sim N(m_j,v_j)\), standardization gives

$$ P(\theta_j>c) = 1-\Phi\left(\frac{c-m_j}{\sqrt{v_j}}\right), \qquad P(a<\theta_j<b) = \Phi\left(\frac{b-m_j}{\sqrt{v_j}}\right) - \Phi\left(\frac{a-m_j}{\sqrt{v_j}}\right). $$

These expressions help check whether a prior matches the intended beliefs. The threshold \(c\), or interval \((a,b)\), should be stated in the effect’s units. For example, a prior mean of zero does not by itself mean that effects are expected to be practically negligible: a large variance can still assign substantial probability to large benefits and harms.

Worked Example: Checking a Prior Against a Benefit Threshold

Suppose positive values represent improvement on a hypothetical symptom score, measured in points. For two arms, assign independent priors \(\theta_1\sim N(0,16)\) and \(\theta_2\sim N(0,16)\). The prior standard deviation for each effect is \(\sqrt{16}=4\) points. Calculate the prior probability that each effect exceeds 3 points, and the probability that both do.

For either arm, standardize the threshold:

$$ P(\theta_j>3) = 1-\Phi\left(\frac{3-0}{4}\right) = 1-\Phi(0.75) \approx 0.226627. $$

Thus, before observing data, each arm has about a 22.66% prior probability of an improvement greater than 3 points. Because the priors are independent, the probability that both effects exceed 3 points is the product of the two marginal probabilities:

$$ P(\theta_1>3,\theta_2>3) = \{1-\Phi(0.75)\}^2 \approx 0.05135995 \approx 0.0514. $$

The joint probability is about 5.14%. This conclusion depends on prior independence; it does not follow merely from the two marginal priors having the same distribution. The calculation also shows why a prior should be discussed in terms of meaningful thresholds, not only by quoting its mean and variance.

Arm-Specific Priors and a Common Prior

There are two common ways to specify the marginal distributions. With arm-specific priors, one may choose different means or variances, such as \(N(m_1,v_1)\) for one arm and \(N(m_2,v_2)\) for another. This can represent a priori differences in plausibility or uncertainty, but those differences should have a scientific or design-based rationale. With a common prior, every arm receives the same marginal distribution \(N(m,v)\). If the effects are still specified as independent, the joint prior density is the product of those identical densities.

Key distinction: A common independent prior means that each arm’s effect has the same prior distribution and that the effects are independent under the prior. It does not mean \(\theta_1=\cdots=\theta_K\), and it does not create prior correlation among the effects. A single shared unknown effect parameter is a different model.

For independent priors, the joint density factors as follows. If \(f_j\) is the normal density with mean \(m_j\) and variance \(v_j\), then independence means that the joint density at \((\theta_1,\ldots,\theta_K)\) is the product of the marginal densities. This factorization also justifies multiplying probabilities for events involving separate effects.

$$ f(\theta_1,\ldots,\theta_K) = \prod_{j=1}^{K} f_j(\theta_j), \qquad P(\theta_1\in A_1,\ldots,\theta_K\in A_K) = \prod_{j=1}^{K}P(\theta_j\in A_j). $$

The probability identity follows because the joint event is a Cartesian product of sets for the separate effects, and the joint density factors; integrating that density over the product set separates into the product of the marginal integrals. This is a prior statement only. It does not say that estimates based on future data will be independent.

Worked Example: Different Prior Variances Across Arms

Consider two hypothetical arms on the same additive outcome scale, where positive effects are beneficial and effects are measured in points. Suppose prior knowledge supports \(\theta_1\sim N(1,4)\) and \(\theta_2\sim N(0,1)\), independently. Compare the prior probabilities that each arm’s effect exceeds 2 points.

For arm 1, the prior mean is 1 point and the standard deviation is \(\sqrt{4}=2\) points:

$$ P(\theta_1>2) = 1-\Phi\left(\frac{2-1}{2}\right) = 1-\Phi(0.5) \approx 0.3085. $$

For arm 2, the prior mean is 0 points and the standard deviation is \(\sqrt{1}=1\) point:

$$ P(\theta_2>2) = 1-\Phi\left(\frac{2-0}{1}\right) = 1-\Phi(2) \approx 0.02275. $$

The priors express different beliefs: arm 1 is centered at a one-point benefit and has more uncertainty, while arm 2 is centered at no effect and is more concentrated. The numerical contrast is substantial, so the analyst should be able to justify it before using these priors. It would be misleading to describe the difference as a finding from the trial; these are assumptions made before considering its outcomes.

Worked Example: What a Common Independent Prior Implies

Suppose three hypothetical arms have independent priors \(\theta_j\sim N(0,16)\), with positive effects measured in points and representing benefit. Calculate the prior probability that all three effects exceed 3 points.

The marginal probability for one arm is \(q=1-\Phi(0.75)\), as in the preceding calculation. Independence gives:

$$ P(\theta_1>3,\theta_2>3,\theta_3>3) = \{1-\Phi(0.75)\}^3 \approx 0.01164. $$

So the probability that all three effects exceed 3 points is about 1.164%. Each arm nevertheless has the same marginal probability, about 22.66%, of exceeding that threshold. The common prior has not forced the effects to have identical values: it has assigned them identical marginal distributions and, under the stated specification, prior independence.

The independence assumption matters. If the effects were dependent, their marginal probabilities alone would not determine the probability that all three exceed the threshold. One would need a joint prior that also specifies their dependence. Identical marginal priors are not enough to supply that information.

Assumptions, Diagnostics, and Alternatives

A normal-prior specification should be checked at the level of both the scientific estimand and the numerical distribution. The following checks are useful before proceeding to any data model:

  • Confirm the effect definition and direction. State what the contrast is, the population and outcome it concerns, and whether positive values mean benefit or harm.
  • Check the units. A prior mean must be in effect units and a prior variance in squared effect units. Confusing a standard deviation with a variance changes the distribution substantially.
  • Translate the prior into probabilities. Calculate probabilities above clinically meaningful benefit or harm thresholds, and over plausible ranges. Ask whether those probabilities reflect the intended prior beliefs.
  • Assess the independence assumption. Independence is a substantive joint assumption, not a consequence of having one prior distribution per arm. If prior information suggests related effects, a joint model that represents that dependence may be more appropriate.
  • Check comparability across arms. A common prior is easiest to defend when the effects have the same definition and scale. Different indications, doses, populations, or prior evidence may motivate different marginal priors.

A simple diagnostic is to compare the prior’s central range and tail probabilities with scientifically plausible effects. For example, a prior can have a plausible mean but implausibly wide tails, or a narrow variance that rules out effects the evidence makes credible. Conversely, assigning different priors to arms without a clear rationale can encode an unintended preference for one arm. These checks are assessments of prior assumptions; they do not establish that a prior is correct.

The main alternatives answer different modeling needs. Arm-specific independent normals allow different prior means and variances while retaining independence. A common independent normal prior imposes the same marginal beliefs across arms but still allows different effect values. A model with a single shared effect parameter instead asserts equality of the modeled effects. A model that introduces dependence among effects requires an explicit joint distribution. These choices should not be conflated: they encode different beliefs, and none is justified merely by the fact that a trial has multiple arms.

Normal priors also have limitations. They assign positive probability to every real value, including extreme values and values in a direction considered implausible. Whether that is negligible depends on the chosen mean, variance, and effect scale. For example, a normal prior on a raw effect can behave poorly if the scientific parameter is constrained. The model’s scale should therefore be chosen before specifying prior numbers, and any alternative distribution should be calibrated to the same substantive beliefs.

Key takeaway: An arm-specific normal prior is interpreted through its mean, variance, effect scale, and beneficial direction. A common independent prior gives every arm the same marginal prior distribution; it neither sets the effects equal nor induces dependence. Check prior probabilities for meaningful effect thresholds before treating the specification as scientifically plausible.

Check Your Understanding

Answer each question, then compare your reasoning with the solutions.

  1. An effect is measured in days, with positive values representing shorter recovery time as defined by the chosen contrast. What are the units of the prior mean and variance?
  2. If \(\theta\sim N(2,9)\), what is the prior standard deviation, and what is \(P(\theta>5)\) approximately?
  3. Two independent arms each have prior probability \(0.20\) of exceeding a clinical threshold. What is the prior probability that both exceed it?
  4. Does assigning two arms the same \(N(0,4)\) prior mean their effects are equal? Explain.
  5. Name one diagnostic for a proposed normal prior and one limitation of the normal distribution on an effect scale.

Solutions. (1) The mean is in days and the variance is in days squared. (2) The standard deviation is \(\sqrt{9}=3\). Standardizing gives \(P(\theta>5)=1-\Phi((5-2)/3)=1-\Phi(1)\approx0.1587\). (3) Independence gives \(0.20\times0.20=0.0400\), or 4.00%. (4) No. The arms have identical marginal prior distributions, but their independently assigned effects can take different values; equality would be a separate model assumption. (5) For example, calculate the prior probability of exceeding a clinically meaningful threshold and compare it with scientific expectations. A normal prior also assigns probability to arbitrarily extreme values, including implausible effects.

Clinical Biostats